Results 241 to 250 of about 1,254,090 (295)

Association between serum tumor markers and diabetic nephropathy in type 2 diabetes patients: a cross-sectional survey in Western China. [PDF]

BMC Endocr Disord
Tao L, Yao T, Zhang Y, Gong Y, Huang L, Zhao Y, Chen N, Yin J, Xue L, Xiong C, Li X, Zhang Y.   +11 more
europepmc   +1 more source

Pan-cancer analysis of the potential of PEA3 subfamily genes as tumor markers. [PDF]

Sci Rep
Guan L, Zeng R, Chen Y, He G, Yao W, Liu Z, Liu H.   +6 more
europepmc   +1 more source

Clinical value of blood routine and tumor markers in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma. [PDF]

Medicine (Baltimore)
Shi W, Jin W, Hong L, Wu H, Hu S.
europepmc   +1 more source

A correlation study of serum tumor markers with systemic lupus erythematosus-associated interstitial lung disease. [PDF]

Front Med (Lausanne)
He X, Ji J, Zhou T, Luo Z, Fang S, Chen X, Liu C, Yan H, Guo L.   +8 more
europepmc   +1 more source

Integrating TNF-α with Established Tumor Markers to Enhance Prognostic Accuracy in Gastric Cancer: A Prospective Observational Study. [PDF]

Biomedicines
Rosu MC, Tarta C, Moldovan S, Neamtu AA, Ardelean A, Capitanio M, Herczeg D, Faur IF, Bende R, Pilat L, Prunoiu VM, Neamtu C, Totolici BD.   +12 more
europepmc   +1 more source

Patterns of Preoperative Tumor Markers Can Predict Resectability and Prognosis of Peritoneal Metastases: A Clustering Analysis. [PDF]

Ann Surg Oncol
Enblad M, Cashin P, Ghanipour L, Graf W.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tumor markers

Current Problems in Surgery, 1982
Several substances, referred to as tumor markers, are associated with neoplasms development. The specificity of these cancer related substances or antigens depends on their nature (onco-fetal antigens, placental antigens) or on their concentration and physico-chemical forms (hormones, exocrine products, enzymes,...).
H P, Ewing, B D, Newsom, J D, Hardy
openaire   +4 more sources

Gynecologic tumor markers

Seminars in Surgical Oncology, 1990
AbstractThe advent of monoclonal technology has increased the potential utility of antibody‐dependent tumor marker assays in gynecologic oncology. The availability of unlimited quantities of several pure monoclonal antibodies directed against novel epitopes on tumor‐associated antigens has permitted development of highly sensitive assays for serum ...
G J, Olt, A, Berchuck, R C, Bast
openaire   +2 more sources

Tumor Markers in Neuroendocrine Tumors

Digestion, 2000
Most neuroendocrine tumors produce and secrete a multitude of peptide hormones and amines. Some of these substances cause a specific clinical syndrome: carcinoid, Zollinger-Ellison, hyperglycemic, glucagonoma and WDHA syndrome. Specific markers for these syndromes are basal and/or stimulated levels of urinary 5-HIAA, serum or plasma gastrin, insulin ...
K, Oberg, E T, Janson, B, Eriksson
openaire   +3 more sources

Viral Tumor Markers

1987
In diagnostic virology, isolation of viruses by culturing infectious material and serological immunoassays have usually met the clinical needs for: 1. accurate identification of the infectious agent, 2. definition of the state of the disease (acute, convalescence, recovery), 3.
T, Löning, K, Milde
openaire   +3 more sources